UBS Group’s Harte-Hanks HHS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $328 | Sell |
152
-55
| -27% | -$144 | ﹤0.01% | 9921 |
|
|
2026
Q1 | $470 | Sell |
207
-230
| -53% | -$653 | ﹤0.01% | 9876 |
|
|
2025
Q4 | $1.31K | Sell |
437
-46,480
| -99% | -$152K | ﹤0.01% | 9633 |
|
|
2025
Q3 | $174K | Sell |
46,917
-1,620
| -3% | -$5.84K | ﹤0.01% | 6752 |
|
|
2025
Q2 | $193K | Buy |
+48,537
| New | +$217K | ﹤0.01% | 6749 |
|
|
2025
Q1 | – | Sell |
-335
| Closed | -$1.73K | – | 10432 |
|
|
2024
Q4 | $1.73K | Buy |
+335
| New | +$2.17K | ﹤0.01% | 9173 |
|
|
2024
Q2 | – | Sell |
-1,414
| Closed | -$10.6K | – | 9746 |
|
|
2024
Q1 | $10.6K | Buy |
1,414
+1,039
| +277% | +$7.91K | ﹤0.01% | 7218 |
|
|
2023
Q4 | $2.55K | Buy |
+375
| New | +$2.5K | ﹤0.01% | 8096 |
|
|
2023
Q3 | – | Sell |
-246
| Closed | -$1.35K | – | 9663 |
|
|
2023
Q2 | $1.35K | Buy |
+246
| New | +$1.67K | ﹤0.01% | 7940 |
|
|
2022
Q4 | – | Sell |
-910
| Closed | -$10K | – | 10882 |
|
|
2022
Q3 | $10K | Buy |
+910
| New | +$12.1K | ﹤0.01% | 8426 |
|
|
2020
Q3 | – | Sell |
-1,816
| Closed | -$6K | – | 8170 |
|
|
2020
Q2 | $6K | Sell |
1,816
-1,068
| -37% | -$2.52K | ﹤0.01% | 7293 |
|
|
2020
Q1 | $5K | Buy |
2,884
+49
| +2% | +$146 | ﹤0.01% | 7289 |
|
|
2019
Q4 | $10K | Sell |
2,835
-332
| -10% | -$986 | ﹤0.01% | 7286 |
|
|
2019
Q3 | $10K | Hold |
3,167
| – | – | ﹤0.01% | 7163 |
|
|
2019
Q2 | $7K | Sell |
3,167
-259
| -8% | -$822 | ﹤0.01% | 7238 |
|
|
2019
Q1 | $12K | Sell |
3,426
-462
| -12% | -$1.61K | ﹤0.01% | 6684 |
|
|
2018
Q4 | $9K | Sell |
3,888
-1,833
| -32% | -$8.74K | ﹤0.01% | 7280 |
|
|
2018
Q3 | $41K | Buy |
+5,721
| New | +$50.3K | ﹤0.01% | 6300 |
|
|
2018
Q2 | – | Sell |
-692
| Closed | -$6K | – | 8089 |
|
|
2018
Q1 | $6K | Sell |
692
-1,748
| -72% | -$16K | ﹤0.01% | 7146 |
|
|
2017
Q4 | $23K | Buy |
2,440
+724
| +42% | +$7.3K | ﹤0.01% | 6447 |
|
|
2017
Q3 | $18K | Buy |
1,716
+443
| +35% | +$4.08K | ﹤0.01% | 6525 |
|
|
2017
Q2 | $13K | Buy |
1,273
+1,266
| +18,086% | +$16K | ﹤0.01% | 6601 |
|
|
2017
Q1 | $0 | Sell |
7
-105
| -94% | -$1.6K | ﹤0.01% | 7769 |
|
|
2016
Q4 | $2K | Buy |
112
+102
| +1,020% | +$1.54K | ﹤0.01% | 7506 |
|
|
2016
Q3 | $0 | Sell |
10
-3
| -23% | -$49 | ﹤0.01% | 7777 |
|
|
2016
Q2 | $0 | Sell |
13
-197
| -94% | -$3.48K | ﹤0.01% | 7825 |
|
|
2016
Q1 | $5K | Buy |
210
+167
| +388% | +$5.13K | ﹤0.01% | 7003 |
|
|
2015
Q4 | $1K | Sell |
43
-294
| -87% | -$11K | ﹤0.01% | 8146 |
|
|
2015
Q3 | $12K | Sell |
337
-686
| -67% | -$30.9K | ﹤0.01% | 7148 |
|
|
2015
Q2 | $61K | Sell |
1,023
-12
| -1% | -$807 | ﹤0.01% | 5828 |
|
|
2015
Q1 | $80K | Sell |
1,035
-426
| -29% | -$32.9K | ﹤0.01% | 5609 |
|
|
2014
Q4 | $114K | Buy |
+1,461
| New | +$95.5K | ﹤0.01% | 5570 |
|
Other funds holding HHS
WCM
KF
RA
UBS Group's HHS Position: Q2 2026 in Review
UBS Group reduced its Harte-Hanks (HHS) stake by 27% in Q2 2026, selling an estimated $144 and leaving 152 shares worth $328. The position accounts for ﹤0.01% of the portfolio, ranked #9921.
UBS Group first reported a position in HHS in Q4 2014 and has held it in 32 quarters since. The position peaked at $193K in Q2 2025. 22 funds tracked by Wall St. Rank hold HHS as of Q2 2026.
- UBS Group held 152 shares of Harte-Hanks worth $328 as of Q2 2026.
- UBS Group sold 55 Harte-Hanks shares in Q2 2026, an estimated $144.
- Harte-Hanks made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9921 holding.
- UBS Group first reported a position in Harte-Hanks in Q4 2014 and has held it in 32 quarters since.
- UBS Group's Harte-Hanks position peaked at $193K in Q2 2025.
- 22 funds tracked by Wall St. Rank held Harte-Hanks as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.